Discover how our single B cell-based AbTheneum platform can transform your antibody discovery efforts with unmatched speed and versatility. Generating thousands of antibody sequences in just three weeks, our platform integrates multiple assays during the discovery phase, ensuring the identification of differentiated antibodies. With over eight years of experience and successful partnerships with leading pharma companies, we have consistently delivered results. We'll also highlight SurfScreen, our innovative module for addressing challenging membrane targets. Our research services are designed to accelerate your pipeline and advance your therapeutic programs efficiently.